Login to Your Account

Other News To Note

Wednesday, February 29, 2012
• BioLineRx Ltd., of Jerusalem, reported that preclinical results demonstrated that BL-7010, a polymer intended to treat celiac disease, reduced gluten toxicity and prevented gluten-induced pathological damage to the small intestine in rodents. The research was published in the February 2012 edition of Gastroenterology.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription